• Update on COVID-19
• Pharmacist Awareness Month at Ontario Schools of Pharmacy
• OPA Thought Leadership Launching During PAM
• University of Toronto Initiates "I’m Pharmacy” Campaign
• ICYMI: OPA Celebrates International Women's Day with Launch of Women of Pharmacy Conference Event
• Board of the Canadian Foundation for Pharmacy Announces New Grant
• Lung Health Foundation Needs Assessment Survey
• Humber College Pharmacy Advisory Committee

• Certified Diabetes Educator (CDE) Preparation Course
• Identifying Drug Interactions
• Managing Your Pharmacy: The Business Essentials

• Ask the Customer Experience and Administration Team

• Disability Insurance – Q & A

• DDD Notice No. 20045 Posted March 10, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification

• Drug Shortage / Supply Health System Alert: Kidrolase

• Uniting as a Profession to Respond to the Needs of Patients During COVID-19
• Ontario Protecting Children and Youth from Dangers of Vaping
• Green Shield Canada Brand-Drug Loyalty Card Policy
• UofT Leslie Dan Faculty of Pharmacy Takes Back the OPA Cup!
• ICYMI: It's Pharmacist Awareness Month!
• Complete the Survey on Opioid Use in Cancer-related Pain

• Opioid Addictions and Substitution Therapy FREE Live Webinar Series - March 11, 2020
• Certified Diabetes Educator (CDE) Preparation Course *2020 Update*
• Implementing Smoking Cessation Services in the Pharmacy *2020 Update*

• Ask the Practice Support Network
• Nominate a Colleague for an OPA Award!

• Did You Know Cancer Is the Leading Cause of Death in Canada?

• DDD Notice No. 20040 posted March 2, 2020 Prescription Forgery Alert
• DDD Notice No. 20039 posted March 2, 2020 Prescription Forgery Alert
• DDD Notice No. 20038 posted March 2, 2020 EO Notice: Reconciliation Adjustment Percentages for 2020/21 to Improve the Value of Pharmacy Payments

• Health Product InfoWatch - February 2020
• Certain Metformin Diabetes Drugs Recalled Due to the Presence of NDMA

• The Winter 2020 Issue of Ontario Pharmacist Magazine is here!
• COVID-19 Resources Available on OPA website
• Last chance: National Pharmacist Survey on Opioid Prescribing and Dispensing Practices
• Kick-off this year's Pharmacist Awareness Month with the OPA Cup!
• Reminder: Deadline to Apply to Allied Health Professional Development Fund is March 2, 2020

• Essential Cannabis Knowledge for Pharmacists Certificate Program
• How-To: Ontario’s Pharmaceutical Opinion Program
• Drugs in Chronic Kidney Disease: Implications for Pharmacists

• Ask the Customer Experience and Administration Team

• Practising in Ontario and One or Two Other Provinces?

• DDD Notice No. 20037 posted February 24, 2020 Prescription Forgery Alert
• DDD Notice No. 20036 posted February 21, 2020 Prescription Forgery Alert
• DDD Notice No. 20035 posted February 20, 2020 ODB Formulary – Edition No. 43, Summary of Changes – February 2020
• DDD Notice No. 20034 posted February 19, 2020 Prescription Forgery Alert
• DDD Notice No. 20033 posted February 19, 2020 Prescription Forgery Alert
• DDD Notice No. 20032 posted February 19, 2020 Prescription Forgery Alert

• OPA Consultation Submission on Proposed Changes to OCP Council Governance and Fees
• ICYMI: COVID-19 Guidance Document for Community Pharmacies
• National Pharmacist Survey on Opioid Prescribing and Dispensing Practices

• *New* Wearable Technology
• Paid Consultations - Opportunities and Timesavers
• Identifying Drug Interactions

• Ask the Practice Support Network

• Planning to Work in Another Province?

• DDD Notice No. 20029 posted February 12, 2020 Elimination of Red and White Health Card - Posters for Display

• ICYMI: OPA's Pre-budget Consultation Submission
• FIP Guidance Resources for Managing Coronavirus in Pharmacy
• New Awards to Celebrate Leslie Dan Faculty of Pharmacy Alumni
• University of Waterloo Survey on Readiness to Assess and Prescribe for Minor Ailments
• ICYMI: Elimination of Red and White Health Cards
• 2nd Coalition of Pharmacists Caring for Aging Canadians (CPCAC) Scientific Meeting

• *Free* Methadone, Buprenorphine and the Community
• Rational Prescribing: Re-Thinking Medications
• *Free* Assessment and Management of Patients with Migraine

• Ask the Customer Experience Administration Team

• Planning to Retire or Moving to Part B?

• DDD Notice No. 20027 posted February 10, 2020 Trillium Drug Program - New Online Application Form and Guide
• DDD Notice No. 20028 posted February 11, 2020 Prescription Forgery Alert

• Drug Shortage / Supply Health System Alert: Dexamethasone, Ranitidine, Tamoxifen February 7, 2020

• Apotex Inc. Recalls Certain Lots of Diabetes Medication APO-Metformin ER (extended release) 500 mg Tablets

• Novel Coronavirus (2019-nCoV) Resources
• Deadline to Apply to Allied Health Professional Development Fund is March 2, 2020

• Opioid Addictions and Substitution Therapy FREE Live Webinar Series
• Essential Cannabis Knowledge for Pharmacists Certificate Program
• Applying NAPRA’s Non-Sterile Compounding Standards into Practice

• Ask the Practice Support Network

• Store Owners, Did You Know?

• DDD Notice No. 20015 Posted February 3, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification
• DDD Notice No. 20016 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20017 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20018 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20019 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20020 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20021 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20022 posted February 4, 2020 Prescription Forgery Alert

• Drug Shortage / Supply Health System Alert: Effient (Prasugrel)

• Health Product InfoWatch - January 2020

• Ministry of Health Emergency Operations Centre Provides More Resources for Novel Coronavirus (2019-nCoV)
• Pillar of Pharmacy Award Nominations

• Certified Diabetes Educator (CDE) Preparation Course
• Essential Cannabis Knowledge for Pharmacists Certificate Program
• Methadone, Buprenorphine and the Community

• Ask the Customer Experience Administration Team

• Shopping for Auto Insurance?
• Last Chance to Avoid an Interruption in Your Professional Liability Insurance

• ODB Formulary – Edition No. 43, Summary of Changes – January 2020

• Last Chance to Have Your Say on Pre-budget Consultations - Complete Our Survey
• University of Toronto: Class of 2023 White Coat Ceremony
• Fluwatch - Register to Monitor Flu Activity
• Clinical Guidelines on Substance Use Disorders in Older Adults from the Canadian Coalition for Seniors' Mental Health
• Resources from the Ontario Caregiver Organization

• Methadone, Buprenorphine and the Community
• Pharmacist Health Coaching – Cardiovascular Program Training Course
• FAQs and a New Drugs Update on Contraception and Abortion Care

• Ask the Practice Support Network
• Looking for Things to Do With the Kids?

• OPA Pharmacy (Store) Insurance

• DDD Notice No. 20009 Posted January 16, 2020 Prescription Forgery Alert
• DDD Notice No. 20010 Posted January 20, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies
• DDD Notice No. 20011 Posted January 21, 2020 Prescription Forgery Alert
• DDD Notice No. 20012 Posted January 21, 2020 Prescription Forgery Alert

• Pharmascience Inc. recalls one lot of prescription antifungal drug PMS-Nystatin Oral Suspension: Product may pose a choking risk